United States
Aug 26, 2026
Authors Kiyomi Tsuyuki, Renee El-Krab, Steven Shoptaw, Nabila El-Bassel, Jordan E. Lake, Manya Magnus, Irene Kuo, David Goodman-Meza, Cecile Denis, Omar Nieto, Julie Franks, Yolanda R. Villareal, Peter Smith, Sydney Bornstein, Philip Andrew, Jayla Harris-Wisecarver,...
Aug 6, 2026
This survey will be a cross-sectional descriptive survey of the knowledge, views, and experiences concerning medications for HIV prevention (PrEP), particularly focusing on lenacapavir, among NYC women who have risk factors for the acquisition of HIV....
Aug 6, 2026
This multicenter randomized clinical trial will test a suite of mHealth tools to increase the use of medication to prevent HIV (PrEP) and improve adherence to PrEP among young men in communities most affected by the HIV epidemic and evaluate the uptake, adherence, and...
Aug 5, 2026
A study of a new formulation of lenacapavir that is designed to be used as a once-yearly intramuscular shot for prevention of HIV from sex. This multicenter study is fully enrolled and in follow up.
Jun 26, 2026
Authors Connor G Wright, Terry L Chern, Tara F Abularrage, Julie Franks, Ann Kahn, Shakir Edwards, Harshit H Chellani, Rashaunna Redd, Alexander W Ying, Siddarth Arumugam, Robert Stanciu, Samuel K Sia, Ellen AB Morrison, Jessica E Justman Abstract Background:HIV...